This message has been sent to you
in compliance with our strict anti-abuse regulations. We will continue
to bring you valuable offers on the products and services that interest
you most. If you do not wish to receive further mailings, please click
below. You may then rest-assured that you will never receive
another email from us again. We
respect all removal requests. UNSUBSCRIBE ME PLEASE
. This message was sent by World Reach Corporation. This message
is an advertisement. Copyright 2000, 2001, 2002 all rights reserved.
Wall Street
Stockwatch
Wasatch Pharmaceuticals:
Company Update
Special Corporate Update WSCH
Company Name
Wasatch Pharmaceuticals
(OTCBB: WSCH)
Current Price
$0.007
52-Week High
$1.95
52-Week Low
$0.0045
News from Wasatch Pharmaceutical (OTCBB:
WSCH) is hard to come by lately. Gary Heesch, CEO of Wasatch,
doesn't buy the idea that a press release every day is productive.
He feels "it is usually perceived as an effort to over- promote
the stock." But what about the future of WSCH? Why
should anyone buy or hold their stock with no news?
Mr. Heesch feels that past news
releases and their record of Company accomplishments speak for themselves.
For example, Wasatch, now in its 18th year of research, has
produced skin care products for the treatment of most common skin
disorders. This puts them years ahead of the competition.
In the last 12 months, WSCH has addressed
a whole new dimension in preparation for launching its products
into the worldwide marketplace, so that millions of people will
finally have access to therapies that allow them to remedy their
skin disorders and live more normal lives. This preparation involved:
(1) A new management team with impressive individual records
of creating billions of dollars in revenue for Oracle, Bausch &
Lomb, and Warner Lambert.
(2) The establishment of a new AISC Distribution Center that
is fully inventoried with products ready for shipment.
(3) Establishing beautiful corporate offices separate from
the company's clinic.
(4) Relocation of the American Institue of Skin Care clinic
to a facility designed to be the prototype for future clinics.
To cap off the last 12 months, patents were filed for five new
products that will be packaged and ready for release to physicians
and hospitals this year. All of these accomplishments translate
into a variety of activites and relationships that will insure
the growth and stability of WSCH.
When pressed to reveal this year's plans, Mr. Heesch wants to reserve
the substance of these activities until they are completed and tucked
away. He did say that existing activities and plans include
the acquisition of existing medical clinics, ongoing discussion
for foreign licensing, conversations with groups of physicians
that can represent as many as 2,000 physicians converting their
patients to Wasatch products for their skin care problems, and
also a possible merger that will expand WSCH's sphere
of influence in the medical community.
As these activities come to fruition, they will be disclosed
to WSCH shareholders and the public in detail. Unlike many companies
struggling with today's economy, Wasatch Pharmaceutical is alive
and well and working towards a productive future.
Stay tuned for plenty more to come from WSCH.
To be removed from future mailings, please respond
to this email with "Remove" in the subject line
DISCLAIMER:
Information within this email contains "forward looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934. Any statements
that express or involve discussions with respect to predictions, expectations,
beliefs, plans, projections, objectives, goals, assumptions or future
events or performance are not statements of historical fact and may
be "forward looking statements."
Forward looking statements are based on expectations, estimates and
projections at the time the statements are made that involve a number
of risks and uncertainties which could cause actual results or
events to differ materially from those presently anticipated. Forward
looking statements in this action may be identified through the use
of words such as "projects", "foresee", "expects", "will," "anticipates,"
"estimates," "believes," "understands" or that by statements indicating
certain actions "may," "could," or "might" occur. All information
provided within this email pertaining to investing, stocks, securities
must be understood as information provided and not investment advice.
Emerging Growth Stock Alert advises all readers and subscribers to
seek advice from a registered professional securities representative
before deciding to trade in stocks featured within this email.
None of the material within this report shall be construed as any
kind of investment advice.
In compliance with the Securities Act of 1933, Section17(b), Emerging
Growth Stock Alert discloses the receipt of ten million unrestricted shares
of WSCH from a third party for the publication of this report and additional services
related to WSCH. Be aware of an inherent conflict of interest resulting
from such compensation due to our intent to profit from the sale of these
shares. All factual information in this report was gathered
from public sources, including but not limited to SEC filings, Company
Press Releases, and the company's website at wasatchpharm.com. Emerging Growth Stock Alert believes
this information to be reliable but can make no guarantee as to its accuracy
or completeness. Use of the material within this email constitutes your
acceptance of these terms.
http://www.launchnet.zaam.net.co.fr|https.launch.goopt.net/launch/info.html
http://www.monsterstocks.net/form.html
This message has been sent to you
in compliance with our strict anti-abuse regulations. We will continue
to bring you valuable offers on the products and services that interest
you most. If you do not wish to receive further mailings, please click
below. You may then rest-assured that you will never receive
another email from us again. We
respect all removal requests. UNSUBSCRIBE ME PLEASE
. This message was sent by World Reach Corporation. This message
is an advertisement. Copyright 2000, 2001, 2002 all rights reserved
http://rd1.hitbox.com/rd?acct=WQ520403BLEA70EN8
http://counter.hitbox.com/a/hitboxfree.cgi
_______________________________________________
Apps-gnustep mailing list
[email protected]
http://mail.gnu.org/mailman/listinfo/apps-gnustep
lmpx.com only provides a reader for public news (NNTP) servers. It is not
affiliated with the servers or forums shown here and is not responsible for
the content of articles, which is written by their respective authors.